Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/02/20248:00AMPR Newswire (Canada)Déclaration du premier ministre à l'occasion de la Journée des Forces armées canadiennes
06/02/20248:00AMPR Newswire (Canada)Statement by the Prime Minister on Canadian Armed Forces Day
06/02/20247:42AMPR Newswire (US)Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
06/02/20247:30AMPR Newswire (US)Vention to democratize industrial automation using NVIDIA AI technologies
06/02/20247:30AMPR Newswire (US)Crimson Cup Coffee & Tea Publishes 2024 Guide on How to Start a Coffee Shop in California
06/02/20247:30AMPR Newswire (Canada)Vention to democratize industrial automation using NVIDIA AI technologies
06/02/20247:30AMPR Newswire (Canada)Message de la gouverneure générale et commandante en chef du Canada à l'occasion de la Journée des Forces armées canadiennes
06/02/20247:30AMPR Newswire (Canada)Message from the Governor General and Commander-in-Chief of Canada on Canadian Armed Forces Day
06/02/20247:00AMPR Newswire (US)OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
06/02/20246:20AMPR Newswire (Canada)/R A P P E L -- Avis aux médias - Itinéraire de la vice-première ministre pour le dimanche 2 juin 2024/
06/02/20246:20AMPR Newswire (Canada)/R E M I N D E R -- Media Advisory - Deputy Prime Minister's itinerary for Sunday, June 2, 2024/
06/02/20246:00AMPR Newswire (Canada)/R E M I N D E R -- Media Advisory - Prime Minister's itinerary for Sunday, June 2, 2024/
06/02/20246:00AMPR Newswire (US)Fast Guard Service Releases Guide to Choosing the Best Fire Watch Service
06/02/20246:00AMPR Newswire (Canada)/R A P P E L -- Avis aux médias - Itinéraire du premier ministre pour le dimanche 2 juin 2024/
06/02/20245:18AMPR Newswire (US)Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
06/02/20245:00AMPR Newswire (Canada)/R E P R I S E -- Avis aux médias - En pleine négociation, les intervenantes en petite enfance de la FIPEQ-CSQ participeront à l'activité de mobilisation de Ma place au travail/
06/02/20245:00AMPR Newswire (Canada)/R E P E A T -- Media Advisory: Infrastructure Announcement in Halifax/
06/02/20245:00AMPR Newswire (Canada)/R E P R I S E -- Avis aux médias : Annonce en matière d'infrastructure à Halifax/
06/02/20244:00AMPR Newswire (Canada)AVIS DE FERMETURE DE RUES : aujourd'hui, dimanche 2 juin, à l'occasion du Tour de l'Île de Montréal
06/02/20241:08AMPR Newswire (Canada)Ontario Lottery and Gaming Corporation - EVENING LOTTERY WINNING NUMBERS - June 1, 2024
06/01/202410:56PMPR Newswire (US)Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC
06/01/202410:30PMPR Newswire (Canada)'A Red Cross for Journalism': Committee to Protect Journalists awarded Canadian Association of Journalists' 2024 Charles Bury Award
06/01/202410:30PMPR Newswire (Canada)« Une Croix-Rouge pour le journalisme » : Le Comité de protection des journalistes reçoit le prix Charles Bury 2024 de l'Association canadienne des journalistes
06/01/202410:30PMPR Newswire (Canada)L'Association canadienne des journalistes honore l'excellence du journalisme canadien de l'année écoulée lors de son gala annuel de remise de prix
06/01/202410:30PMPR Newswire (Canada)Canadian Association of Journalists celebrates excellence in Canadian journalism from the past year at annual awards gala
06/01/20247:25PMPR Newswire (US)Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
06/01/20247:17PMPR Newswire (US)CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
06/01/20246:13PMPR Newswire (US)GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024 ASCO A
06/01/20245:09PMPR Newswire (US)LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
06/01/20245:06PMPR Newswire (US)NAISMA Announces PlayCleanGo® Awareness Week 2024: Real People, Real Stories